Discuss the role of the judiciary in prompting regulatory action on public health, with reference to food labelling.

Front-of-pack labelling (FoPL) — a label declaring levels of sugar, salt and saturated fat on packaged food — is recommended by the WHO as a policy tool for healthier consumer choices [3]. Its recent movement in India, driven by Supreme Court monitoring of the food regulator, illustrates how courts convert the right to health under Article 21 into administrative action.

Judiciary as a catalyst for delayed regulation

• Breaking regulatory inertia: a Parliamentary panel had earlier flagged that FSSAI was yet to frame food labelling standards despite its mandate [4]; sustained judicial hearings made this delay costly.
• Continuing mandamus: in 3S and Our Health Society v. Union of India (2025) the Court directed the expert committee to report within a fixed period and retained the matter for compliance [5].
• Concrete outcome: FSSAI has now told the Court it will adopt a single-phase rollout, seeking four months to finalise draft regulations and offering food business operators a 365-day implementation window [1].

Constitutional and institutional basis

• Article 21 (health as part of life) read with Article 47 (duty to raise nutrition and public health) supplies the judicial entry point.
• The Court does not legislate: the label must still come as subordinate legislation under the Food Safety and Standards Act, 2006 [2], preserving FSSAI's technical discretion.

Limits of the judicial route

• Courts lack nutritional expertise; thresholds and label design remain executive calls [3].
• A voluntary transition period can dilute compliance, showing that judicial orders secure timelines, not outcomes [1].
• Case-by-case intervention is no substitute for routine parliamentary and regulatory accountability.

The food-labelling episode shows the judiciary functioning not as a rule-maker but as a timekeeper of governance, compelling a statutory regulator to act on an acknowledged public-health need. The durable solution lies in FSSAI notifying clear, mandatory and time-bound labelling norms aligned with WHO guidance [3], with periodic legislative oversight — so that the right to health is realised through regulation rather than repeated litigation.